|
🐜
|
Combination therapy with oncolytic viruses and immune checkpoint inhibitors
18 auth.
M. Chiu,
Edward Armstrong,
V. Jennings,
S. Foo,
E. Crespo-Rodriguez,
G. Bozhanova,
Emmanuel C Patin,
M. McLaughlin,
D. Mansfield,
Gabriella Baker,
...
L. Grove,
M. Pedersen,
J. Kyula,
V. Roulstone,
A. Wilkins,
F. McDonald,
K. Harrington,
A. Melcher
|
5 |
2020 |
5
🐜
|
|
🐜
|
CD4 T cell dynamics shape the immune response to combination oncolytic herpes virus and BRAF inhibitor therapy for melanoma
22 auth.
G. Bozhanova,
J. Hassan,
Lizzie Appleton,
V. Jennings,
S. Foo,
M. McLaughlin,
Charleen M. L. Chan Wah Hak,
Emmanuel C Patin,
E. Crespo-Rodriguez,
Gabriella Baker,
...
Edward Armstrong,
M. Chiu,
H. Pandha,
Adel Samson,
V. Roulstone,
J. Kyula,
R. Vile,
F. Errington-Mais,
M. Pedersen,
K. Harrington,
M. Ono,
A. Melcher
|
3 |
2022 |
3
🐜
|
|
🦁
|
Combination of oncolytic Maraba virus with immune checkpoint blockade overcomes therapy resistance in an immunologically cold model of advanced melanoma with dysfunctional T-cell receptor signalling
20 auth.
Edward Armstrong,
M. K. Chiu,
Shane Foo,
Lizzie Appleton,
P. Nenclares,
Anton Patrikeev,
Nitya Mohan,
M. McLaughlin,
G. Bozhanova,
Julia Hoebart,
...
V. Roulstone,
Emmanuel C Patin,
Malin Pedersen,
J. Kyula,
M. Ono,
F. Errington-Mais,
John Bell,
Kevin J. Harrington,
A. Melcher,
V. Jennings
|
0 |
2024 |
0
🦁
|
